Transposable elements and their potential role in complex lung disorder

Transposable elements (TEs) account for nearly half (approximately 45%) of the human genome, which is in contrast to the functional genes that constitute a smaller proportion (approximately 5%) of the human genome [1]. Based on the mechanism of transposition, TEs are classified as class 2 elements or DNA transposons (‘cut and paste’ mechanism of DNA intermediates) and class 1 elements or retrotransposons (‘copy and paste’ mechanism of RNA intermediates) [1, 2]. Of these, retrotransposons are the most important TEs because they can amplify and increase the host genome size. This ability to move enables class 1 elements to strongly affect genome evolution. Retrotransposons are further subdivided into long terminal repeat (LTR) elements and non-LTR elements.

Long interspersed nuclear elements (LINEs) are non-LTR elements that lack LTRs at their ends. Most LINEs belong to the LINE-1 (or L1) family and are the only TEs capable of transposing autonomously, which constitute approximately 17% of the human genome [1, 3]. Although majority of L1s are rendered inactive as molecular fossils by 5′ truncations and inversions [4], there are still approximately 80–100 active retrotransposition-competent L1s (RC-L1s). An active L1 is approximately 6 kb in length, containing a 5′-UTR, 2 open reading frames (ORF1 and ORF2) and a 3′-UTR with the characteristic poly (A) tail (Figure 1a) [3, 5]. L1 elements either have cis or trans preference [6]. Proteins coded by L1s with cis preference (ORF1p and ORF2p) act on other L1 RNAs to aid nuclear import and integration into the genome (Figures 1b, 2a) [7]. Proteins coded by L1s with trans preference assists in the translocation of other non-autonomous elements such as short interspersed nuclear elements (SINEs) (Figure 1a) [6].

Genome integrity is a crucial determinant in passing down genetic information from one generation to another. TE-associated genetic alterations such as aberrant mRNA splicing, introduction of premature stop codon and transcriptional disruptions threaten this integrity. Double-stranded breaks (DSBs) generated by TEs [8] produce tracts of non-allelic sequences that can derange major homology-based repair system (homologous recombination repair, HRR). This in turn can result in large-scale insertion/deletions (INDELS), inversions and chromosomal rearrangements through non-allelic homologous recombination (NAHR) [9]. Thus far, more than 25 insertion-mediated disorders have been reported [10]. Furthermore, TEs play a crucial role in the genesis of structural variations such as microsatellites repeats [11]. For instance, before integration, L1s and SINEs undergo 3′ extension to generate a 3′-A-rich tail [3, 5], which directs further integration of TEs [12]. These newly integrated retrotransposons can readily mutate to pro-microsatellite sequences and turn in to highly unstable structures by processes such as polymerase slippage [13], resulting in microsatellite instability (MSI). Such an association has been reported in microsatellite-initiating mobile elements (mini-me) of dipteran taxa [14] that carry pro-microsatellite sequences. After the insertion of mini-me into the genome, slippage-associated mutation introduces variation in these loci to generate microsatellites. The mechanism observed in dipteran genomes seems to be common among eukaryotes where elements with cryptic repeats tend to decay into microsatellites through insertion-mediated mutations [14].

Microsatellites exhibit high mutation rate compared to point mutations, which makes them a potent regulator of gene expression [15]. MSI, a type of genomic instability, is a modulator in several malignant and benign diseases caused by the instability in tandem repeats (2–6 bp) of microsatellites [16]. MSI is studied by amplifying microsatellites that are proximal to a putative gene and examining the shift in electrophoretic pattern caused by the addition or deletion of repetitive units [17]. Genetic studies on MSI have already shown its implications as acquired mutations in benign lung conditions [18] and as a potential marker for asthma, chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis [17, 19, 20]. Epithelial cells lining the trachea, bronchi and bronchioles of the lungs are prone to such mutations [21]. These mutations can persist even after smoking cessation, possibly explaining the non-intractable inflammation condition in ex-smokers. Studies on bronchial epithelium of smokers [22] further validate this theory of epithelium cells as the prime cells of MSI activity. Furthermore, MSI is significantly associated with exacerbation frequency in patients with COPD [23]. COPD exacerbation is caused by the acute worsening of respiratory symptoms along with physiological deteriorations. Because its frequency is related to disease severity [24], the possible role of MSI in regulating this frequency should be an interesting avenue to study.

COPD is a complex lung disorder and is the leading cause of morbidity and mortality. The 2011 WHO estimates indicate that 64 million people have COPD; moreover, COPD is reported to cause 3 million deaths worldwide, making it the fifth leading cause of death worldwide [25]. COPD manifests as co-occurrence of conditions such as chronic bronchitis (inflammation of the bronchi) and emphysema (alveolar wall destruction) [26]. Cigarette smoking is the most common cause of COPD and is associated with inflammation, high cell turnover and oxidative stress, leading to proteolytic damage of the lungs. Nearly all smokers develop inflammation, but only a fraction (10%–15%) develop COPD and even fewer (1%–3%) develop lung cancer [21]. This peculiar distribution urges one to postulate that acquired (somatic) mutations may be a prerequisite in the pathobiology of COPD. Estimates show that genetic alterations accounts for up to 50% of COPD cases [27]. Marked variability in the development of airflow obstruction among smokers [28], familial aggregation of pulmonary function in monozygotic and dizygotic twins [29], and differences in clinical outcome compared with controls in first-degree relatives [30] are some of the facts that support the claim of genetic factors in COPD development. In addition, linkage and candidate gene association studies have identified an array of genetic determinants in the pathogenesis of COPD [26]. Although there are reports on genomic instability events in complex disorders such as COPD and cancer [15, 31], the association of these events with TE activity remains obscure. Therefore, it is possible that TEs such as L1s may play a vital role in disease phenotype by introducing somatic mutations and thereby affecting genome integrity.

TEs can be acquired as somatic mutations over a lifetime; presence of L1 activity in tumour cells but not in the surrounding healthy cells supports this hypothesis [32]. Propagation of TEs in the somatic line is facilitated by their expansion in germ cells or in the embryonic stage. In addition, retrotransposition events occurring in germ cells greatly increase the chance of TE propagation to further generations [33]. For instance, family studies on ocular disease show that mothers of patients exhibit both somatic and germline mosaicism for L1 insertion in the disease gene, suggesting the possibility of retrotransposition during embryogenesis [34]. Retrotransposition events occurring during developmental stages can create somatic mosaicism. Kano et al. (2009) studied such occurrences where L1 RNA was found in embryonic cells and adult tissues such as the lung [35]. Further quantitative analysis showed that frequency of retrotransposition was higher in somatic tissues as in reproductive cells. A recent study supports this claim because in this study, the level of L1 RNA in the oesophagus and lung was same as that in HeLa cells [36]. Ever increasing results from molecular studies on transgenic models emphasise the risk of such genetic alterations in the development of organs. It is possible that active L1-mediated retrotransposition can disrupt the genes that regulate lung growth in early life, resulting in developmental deformity. This may further lead to lung damage by host machinery (protease/anti-protease imbalance) or by environmental factors (cigarette smoking, pollutants). For instance, it is already known that epigenetic changes during lung development play a vital role in the development of bronchopulmonary dysplasia (BPD) [37] and that any associated lower lung functions can ultimately result in the development of COPD [38].

The study of heritable non-coding variations is a hot topic, particularly in cancer biology. DNA methylation is one such epigenetic regulator that plays a decisive role in developmental biology and pathobiology by processes such as X-chromosome inactivation and retrotranscription silencing [39]. Approximately one-third of the DNA methylation occurs in mobile elements such as Alu and L1s [40], thus making them inactive and surrogate markers of global methylation analysis. These sites can be hypomethylated by environmental influences, leading to genome instability and altered gene expression [41]. Reports on the association between global hypomethylation and genomic instability [20] suggest that L1s that are hypomethylated in airway epithelial cells are associated with higher levels of microsatellite instability. A recent study supports this hypothesis by showing the association between hypomethylation of L1 elements and faster rate of decline in lung function measures such as FEV1 and FVC [42]. Because lung function tests are a major determining factor for diagnosing lung disorders and measuring their severity, the impact of hypomethylation on lung function is intriguing. Other environmental factors such as wood smoke exposure may also contribute in this type of association [43]. Environmental factors are a known source of oxidative stress, and any associated epigenetic alterations at the microsatellite level manifests as acquired mutations, resulting in MSI incidence [44]. Such instability events have already been studied in COPD patients by examining the by-product of oxidant-DNA damage [8-hydroxydeoxyguanosine (8-OHdG) marker] [31].

In recent years, there has been an interest in studying the effects of oxidative stress on epigenetic gene regulation by DNA methylation. Oxidative stress caused by oxidant/anti-oxidant imbalance plays a central role in the pathogenesis of COPD [45]. Oxidant release results in the inactivation of anti-proteases, neutrophil sequestration and gene expression of pro-inflammatory cytokines. Cigarette smoke is an exogenous source of such oxidants that contain a high proportion of free radicals, both in tar and gaseous phase. The smoke interacts with the epithelial lining fluid to form cigarette smoke condensate, which in turn produces more reactive oxygen species [46]. In addition, under stress, inflammatory cells (neutrophils and macrophages) can act as endogenous source of oxidants, which in turn damage the components of lung matrix (emphysema) by proteolytic cleavage [45].

Under oxidative conditions, GC-rich sites are highly susceptible, and guanine with the lowest redox potential [47] oxidizes to guanyl neutral radical. These neutral radicals react with superoxides from cigarette smoke to form 8-OHdG [48]. 8-OHdG, a stable oxidation product, inhibits the binding capacity of DNA methyltransferase, resulting in the demethylation of guanine [49] and cytosine residues [50]. Furthermore, 8-OHdG can cause transversions (G > T) that reduce methylation hotspots (CpG dinucleotides), leading to more hypomethylation [51]. Because the susceptibility to oxidative stress depends on the base composition, clusters of GC-rich CpG dinucleotides can serve as major targets. For instance, the L1 mRNA is bicistronic (ORF1 and ORF2) in nature, with 5′-UTR having a high GC content (approximately 60%) [52, 53]. In one study on bladder cancer, patients with increased oxidative stress exhibited hypomethylation of L1 elements [54]. Similarly, global methylation analysis on lung adenocarcinoma samples showed hypomethylation of L1s that resulted in increased mobility and subsequent gene disruption [20]. Oxidative stress-induced demethylation can be a result of environmental factors such as smoke exposure, ageing, UV radiation and lifestyle factors. For instance, prenatal exposure to tobacco smoke is significantly associated with global (L1s and Alu) demethylation in adulthood [55]. In addition, cigarette smoking along with the inhalation of traffic particles decreases the methylation of L1 in blood DNA [56]. All these studies point to oxidative stress and its role in the methylation pattern of TEs. Under oxidative stress, these sites can undergo hypomethylation, resulting in the activation and transposition of L1s (Figure 2a); this can lead to deleterious structural alterations in the genome (mutant cells) [41] followed by a cascade of signalling events (Figure 2b). Such events can bring in cell death and/or inflammatory response with a continuous cycle of inflammation leading to continued decline of lung function. All these studies clearly suggest that these are not isolated events in the development of COPD and that oxidative stress mediated epigenetic changes plays a central role in the pathogenesis.

Marked variability in the distribution of active TEs between individuals is a direct consequence of their activity in somatic tissues and low selection pressure encountered by these elements. It enables them to evolve rapidly at different sites that make their identification in the genome arduous. Over the last 2 decades, new approaches have been applied for identifying mobile elements. Earlier studies mostly used previous knowledge of mutant genes in characterizing the mobile elements by cloning and sequencing [11, 57], which was further refined by the advent of tools such as PCR [58]. The sheer complexity and vast distribution of these elements makes their identification a mammoth task, with massive data pouring in from new applications such as next-generation sequencing (NGS).

A few of these methods such as de novo discovery and homology-based methods are briefly discussed. The algorithm for detecting inserts in de novo method usually involves reading shotgun sequence reads and matching the repeat sequences, followed by clustering the matched pairs to give a consensus sequence of a TE family [59]. Unlike the de novo sequencing method, homology-based approach uses previous knowledge of TE sequences, such as sequence similarity, in identifying similar class TEs with a low copy number. Figure 3 discusses the main theme of computational study in repetitive elements; putative L1 insertions are identified by comparing clusters of consensus alignment from the same sequence reads. A sequence pair read that is aligned to the reference genome is concordant; hence, discordant alignment that does not match paired-end expectations could represent novel structural variant (SV) sites [60]. Recent studies enhanced the sensitivity and specificity of this procedure by using refined versions of the algorithm that targets the diploid nature of the genome [61]. As a valuable addition to the sequence paired-end read alignment, Ewing et al. (2010) used the orientation and structural characteristics of the reads to identify 1016 novel L1 insertions [62].

Research interest in SVs has increased exponentially over the past decade, and with the advent of screening technologies, approximately 5000 insertions have been reported thus far [63]. Because most reported insertions are scattered across other databases leading to redundancy, a compiled non-redundant list is eminent. Database of Retrotransposition Insertion Polymorphism (DbRIP) represents a comprehensive list of human genome variations (SINE, Alu and LINE). Data from published journals are collected and compiled into a non-redundant list of RIPs. The design of the database is based on simple genome browser style with graphical visualization of RIP for easy navigation and information retrieval. Classification of reported RIPs is based on class, family and subfamily, including data on the size of insertion, chromosomal position, disease association and PCR conditions with expected amplicon sizes and reference(s). Such a tool, with effective documentation, gives a much clearer picture of RIPs in the line of SNPs and CNVs. Now, with the advent of next-generation platform and organized data, it is possible to study the role of these elements in shaping the genome structure and their functional impact.

At least 4 principal mechanisms, inflammation, protease-anti-protease imbalance, oxidative stress and apoptosis, have been identified in the pathogenesis of COPD. Of these, the oxidative stress plays a pivotal role in COPD pathogenesis because it directly injures the respiratory tract and regulates other mechanisms.

Oxidative stress elicits inflammatory response and inhibits the DNA repair system in a dose-dependent manner that may be altered at the microsatellite level, resulting in genome instability. The vast distribution and complexity of mobile genetic elements in the genome makes another strong argument in genomic instability. In addition to acting as insertional mutagens, alterations such as deletions, inversion and duplication can be attributed to the translocation of these active mobile elements. Studies on lung barrier epithelial cells have proven the effect of airway inflammation and oxidative stress on genome instability. Upon exposure to cigarette smoke, barrier epithelial cells undergo epigenetic alterations that can trigger mobile elements such as L1s, thereby influencing multiple molecular pathways that enhance inflammatory signals. Novel L1 sites can be identified by performing whole genome analysis of epithelial cell DNA from smokers (COPD), ex-smokers (no COPD) and healthy controls against a reference genome. Such new L1 insertions can be compared against the profiles of microsatellite markers in patient samples to study the relationship between mobile genetic elements and genome instability and their potential role in a complex disorder such as COPD.